Use of aromatase inhibitors in prepn. of drug for treating relative androgend efficiency in men
PCT No. PCT/EP95/03733 Sec. 371 Date Jun. 13, 1997 Sec. 102(e) Date Jun. 13, 1997 PCT Filed Sep. 22, 1995 PCT Pub. No. WO96/09057 PCT Pub. Date Mar. 28, 1996Male menopause is characterized by significant decreases in serum levels of bioavailable androgens. The administration of aromatase inhibitors...
Saved in:
| Main Authors | , , |
|---|---|
| Format | Patent |
| Language | English |
| Published |
02.04.2003
|
| Edition | 7 |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | PCT No. PCT/EP95/03733 Sec. 371 Date Jun. 13, 1997 Sec. 102(e) Date Jun. 13, 1997 PCT Filed Sep. 22, 1995 PCT Pub. No. WO96/09057 PCT Pub. Date Mar. 28, 1996Male menopause is characterized by significant decreases in serum levels of bioavailable androgens. The administration of aromatase inhibitors to men experiencing male menopause can remedy the relative androgen deficiency in men while at the same time approximating the physiological hormonal ratio of androgens to estrogens. |
|---|---|
| AbstractList | PCT No. PCT/EP95/03733 Sec. 371 Date Jun. 13, 1997 Sec. 102(e) Date Jun. 13, 1997 PCT Filed Sep. 22, 1995 PCT Pub. No. WO96/09057 PCT Pub. Date Mar. 28, 1996Male menopause is characterized by significant decreases in serum levels of bioavailable androgens. The administration of aromatase inhibitors to men experiencing male menopause can remedy the relative androgen deficiency in men while at the same time approximating the physiological hormonal ratio of androgens to estrogens. |
| Author | U-F. HABENICHT A. RADLMAIER F. NEUMANN |
| Author_xml | – fullname: A. RADLMAIER – fullname: U-F. HABENICHT – fullname: F. NEUMANN |
| BookMark | eNqNizsOwjAQBV1Awe8OewEQIbmBBaKigjoyyXNiKdm11gaJ25NIHIDqzZNm1mbBwliZ-pFA4smpjC676QTuwzNk0TQhRUXkw2y0-urIi1JWuBy4I8UwwRvkuFXpwC3B-9AEcPOZ4xG8NUvvhoTdbzeGLue7ve4RpUaKrgEj1_ZWFMfqVJXWln8oXxcPPfQ |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| Edition | 7 |
| ExternalDocumentID | CN1104243CC |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_CN1104243CC3 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 13:18:52 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_CN1104243CC3 |
| Notes | Application Number: CN19951095216 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20030402&DB=EPODOC&CC=CN&NR=1104243C |
| ParticipantIDs | epo_espacenet_CN1104243CC |
| PublicationCentury | 2000 |
| PublicationDate | 20030402 |
| PublicationDateYYYYMMDD | 2003-04-02 |
| PublicationDate_xml | – month: 04 year: 2003 text: 20030402 day: 02 |
| PublicationDecade | 2000 |
| PublicationYear | 2003 |
| RelatedCompanies | SCHERING AG |
| RelatedCompanies_xml | – name: SCHERING AG |
| Score | 2.569607 |
| Snippet | PCT No. PCT/EP95/03733 Sec. 371 Date Jun. 13, 1997 Sec. 102(e) Date Jun. 13, 1997 PCT Filed Sep. 22, 1995 PCT Pub. No. WO96/09057 PCT Pub. Date Mar. 28,... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | Use of aromatase inhibitors in prepn. of drug for treating relative androgend efficiency in men |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20030402&DB=EPODOC&locale=&CC=CN&NR=1104243C |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8gGvVNUSN-pQ9mb1PYB4yHxYQOQkwYxIDhjWxrC3uwW8bQf99rZeqLvjXX9tJeev1d27srwL3wWE_0Ima2E9s2HZ60TKQ4ZsuNXY85Xs9N1IX-OOyM5s7zwl3UYF3Fwug8oR86OSJqVIL6Xur9Ov-5xAq0b-XmMU6RlD0NZ35gVKdjPJy3LCPo-4PpJJhQg1Kfhkb44iPKOZZj0z3YRyO6q3Rh8NpXMSn5b0AZnsDBFHnJ8hRqXDbgiFb_rjXgcLx77sbiTvM2Z7CcbzjJBImKDG1MhB6SynUap-qzHCySvOC5fFAtWLFdETRFifYhR2QiX_Eq75xEKjsBrhhGuM4cocIuVec3Ls-BDAczOjJxpMtvoSxpWE2J2hdQl5nkl0Bc4VlxknQ6KAdHPbC0uzHrRqIthMcF401o_snm6p-6azjWXmzKZcW6gXpZbPktonEZ32lBfgJZCpDN |
| link.rule.ids | 230,309,783,888,25576,76876 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8gGvFNUQN-9sHsbQr7gPGwmNBBUGEQA4a3ZR-t7MFtGUP_fa-VqS_61lzbS3vp9Xdt764AN9yKerznR2o71HXVYGFLRYqhtszAtCLD6pmhuNCfuJ3RwnhcmssKrMpYGJkn9EMmR0SNClHfC7lfZz-XWI70rVzfBTGS0vvh3HaU8nSMh_OWpjh9ezCbOlOqUGpTV3GfbUQ5QzN0ugO7aGB3hS4MXvoiJiX7DSjDQ9ibIa-kOIIKS-pQo-W_a3XYn2yfu7G41bz1MXiLNSMpJ36eoo2J0EPiZBUHsfgsB4sky1mW3IoWUb55JWiKEulDjshEvuJV3hnxRXYCXDERYTJzhAi7FJ3fWHICZDiY05GKI_W-heJRt5wS1U-hmqQJawAxuaUFYdjpoBwM8cDS7gZR1-dtzi3GI9aE5p9szv6pu4baaD4Ze-MH9-kcDqRHm3Bf0S6gWuQbdonIXARXUqifUGqTwA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Use+of+aromatase+inhibitors+in+prepn.+of+drug+for+treating+relative+androgend+efficiency+in+men&rft.inventor=A.+RADLMAIER&rft.inventor=U-F.+HABENICHT&rft.inventor=F.+NEUMANN&rft.date=2003-04-02&rft.externalDBID=C&rft.externalDocID=CN1104243CC |